![Mark Beveridge](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Beveridge
Finanzdirektor/CFO bei
MOBERG PHARMA AB
Profil
Mark Beveridge currently works at Biosergen AB, as Chief Financial Officer from 2025 and Moberg Pharma AB, as Vice President-Finance from 2015.
Mr. Beveridge also formerly worked at OncoZenge AB, as Chief Financial Officer.
Mr. Beveridge received his undergraduate degree from the University of Western Sydney.
Aktive Positionen von Mark Beveridge
| Unternehmen | Position | Beginn |
|---|---|---|
| MOBERG PHARMA AB | Finanzdirektor/CFO | 01.01.2015 |
| BIOSERGEN AB | Finanzdirektor/CFO | 24.07.2025 |
Ehemalige bekannte Positionen von Mark Beveridge
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOZENGE AB | Finanzdirektor/CFO | - |
Ausbildung von Mark Beveridge
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
47
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Western Sydney
 University of Western Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
OncoZenge AB
 OncoZenge AB Pharmaceuticals: MajorHealth Technology Operates pharmaceutical company that develops products for supportive care of cancer patients | Health Technology |
Biosergen AB
 Biosergen AB BiotechnologyHealth Technology Operates as a biotechnology company that develops antifungal drugs | Health Technology |
